Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04219371 · ClinicalTrials.gov registry record
Reference Range Study for the Quantra QStat System
A clinical trial of Coagulation Disorder, sponsored by HemoSonics.
- Completed
- Registry status
- 140
- Enrollment target
- 3
- Study locations
NCT04219371 is a study of Coagulation Disorder that has completed, run by HemoSonics. The registered enrollment target is 140 participants. The trial reports 3 study locations across 3 states.
The verdict
NCT04219371, a study of Coagulation Disorder, has completed, sponsored by HemoSonics.
- COMPLETED
- Registry status
- 140 participants
- Enrollment target
- 3
- Study locations
Study Summary
The objective is to determine the reference range intervals for the parameters reported by the Quantra System with the QStat Cartridge.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Quantra System
Study Locations (3)
Georgia
- WR-Mount Vernon Clinical Research, LLC - Sandy Springs
North Carolina
- M3 Wake Research - Raleigh
Tennessee
- WR-ClinSearch, LLC - Chattanooga
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 140 participants |
| Start Date | 2020-01-07 |
| Est. Completion | 2020-06-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04219371
The ClinicalTrials.gov registry entry for NCT04219371 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 140 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is HemoSonics, which has 24 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Coagulation Disorder appearing as the primary indexed condition, and to 1 intervention - of which Quantra System is the first listed.
NCT04219371 reports 3 study locations spanning 3 distinct geographic areas - top geographies include Georgia, North Carolina, Tennessee.
Frequently Asked Questions
What is clinical trial NCT04219371 about?
NCT04219371 is a clinical study titled "Reference Range Study for the Quantra QStat System". The objective is to determine the reference range intervals for the parameters reported by the Quantra System with the QStat Cartridge.
What is the current status of trial NCT04219371?
This trial is currently completed. The enrollment target is 140 participants. The study started on 2020-01-07. Estimated completion is 2020-06-30.
What conditions does trial NCT04219371 study?
This clinical trial studies the following conditions: Coagulation Disorder.
What interventions are being tested in trial NCT04219371?
The interventions under investigation include: Quantra System (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04219371?
This trial is sponsored by HemoSonics, which has 24 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04219371 being conducted?
This trial has 3 study locations across Georgia, North Carolina, Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Coagulation Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.